MedPath

ICAHN School of Medicine At Mount Sinai

ICAHN School of Medicine At Mount Sinai logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1963-01-01
Employees
5K
Market Cap
-
Website
http://www.mssm.edu

Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children

Phase 4
Completed
Conditions
Attention Deficit Disorder With Hyperactivity
Interventions
First Posted Date
2005-09-16
Last Posted Date
2018-06-06
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
232
Registration Number
NCT00183391
Locations
🇺🇸

University of Illinois, Chicago - Institute for Juvenile Research, Chicago, Illinois, United States

🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia

Phase 4
Completed
Conditions
Schizophrenia
Psychotic Disorders
Interventions
Drug: Placebo
First Posted Date
2005-09-12
Last Posted Date
2015-04-09
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
76
Registration Number
NCT00158223
Locations
🇺🇸

Pilgrim Psychiatric Center, W. Brentwood, New York, United States

🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

🇺🇸

Manhattan Psychiatric Center, New York, New York, United States

Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder

Not Applicable
Completed
Conditions
Schizotypal Personality Disorder
Interventions
Drug: Placebo
First Posted Date
2005-09-12
Last Posted Date
2016-08-04
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
25
Registration Number
NCT00158028
Locations
🇺🇸

Bronx VA, Bronx, New York, United States

Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority Communities

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Behavioral: Improving the Delivery of Effective Care to Minorities
First Posted Date
2005-09-05
Last Posted Date
2013-12-03
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
1164
Registration Number
NCT00145197
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

A Pilot Trial of Intravenous (IV) Pamidronate for Low Back Pain

Phase 1
Conditions
Low Back Pain
Interventions
First Posted Date
2005-01-14
Last Posted Date
2010-01-07
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
44
Registration Number
NCT00101790
Locations
🇺🇸

The Mount Sinai Medical Center, New York, New York, United States

Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix

Phase 2
Completed
Conditions
Cervical Cancer
First Posted Date
2004-03-05
Last Posted Date
2013-07-10
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Registration Number
NCT00005965
Locations
🇺🇸

Saint Vincent Catholic Medical Center of New York, New York, New York, United States

🇺🇸

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States

🇺🇸

New York Presbyterian Hospital - Cornell Campus, New York, New York, United States

and more 3 locations

Switching Medication to Treat Schizophrenia

First Posted Date
2002-09-05
Last Posted Date
2016-04-28
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
219
Registration Number
NCT00044655

Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study

Completed
Conditions
Childhood Absence Epilepsy
Epilepsy
Seizures
First Posted Date
2002-07-22
Last Posted Date
2016-06-01
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
185
Registration Number
NCT00041951
Locations
🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

Study of Fluoxetine in Adults With Autistic Disorder

Not Applicable
Completed
Conditions
Autistic Disorder
First Posted Date
2001-12-07
Last Posted Date
2015-03-25
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
48
Registration Number
NCT00027404
Locations
🇺🇸

Mount Sinai School of Medicine, New York, New York, United States

Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency

Not Applicable
Completed
Conditions
Common Variable Immunodeficiency
First Posted Date
2000-02-25
Last Posted Date
2015-03-25
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Target Recruit Count
48
Registration Number
NCT00004695
© Copyright 2025. All Rights Reserved by MedPath